NCT01059643 2019-09-18A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckEli Lilly and CompanyPhase 2 Completed103 enrolled 14 charts
NCT00094809 2018-10-17Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerAmgenPhase 2 Completed252 enrolled 19 charts
NCT00911170 2017-12-29PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyAmgenPhase 3 Completed847 enrolled 21 charts